Immix Biopharma, Inc.IMMXNASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank40
3Y CAGR-70.4%
5Y CAGR+62.8%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-70.4%/yr
Annual compound
5Y CAGR
+62.8%/yr
Recent deceleration
Percentile
P40
Within normal range
vs 5Y Ago
11.4x
Strong expansion
Streak
3 yr
Consecutive declineCompressed
PeriodValueYoY Change
20242.33-56.3%
20235.32-54.6%
202211.70-87.0%
202190.01+89031.8%
20200.10-50.3%
20190.20-